Alzheimer's Disease: Carers
Commons · Question 118047 · Tabled 4 Mar 2026 · Department of Health and Social Care · Official record
Answered 12 Mar 2026
Question
Asked by Joe Robertson
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of novel treatments on the unpaid care costs associated with Alzheimer’s disease.
Answer
Answered by Zubir Ahmed, 12 Mar 2026
The National Institute for Health and Care Excellence (NICE) is the independent body that develops recommendations for the National Health Service on whether new licensed medicines should be routinely funded by the NHS based on an assessment of clinical a...